Publication

Article

Pharmaceutical Commerce

Pharmaceutical Commerce - February 2022
Volume17
Issue 1

2022 Pharma 3PL Service Provider Directory

Download the 2022 Pharma 3PL Service Provider Directory.
Download Issue PDF
Articles in this issue
Pharmaceutical Commerce - February 2022 Issue (PDF)
Pharmaceutical Commerce - February 2022 Issue (PDF)
A Lowdown on Logistics
A Lowdown on Logistics
The Shifting Course in Logistics Support
The Shifting Course in Logistics Support
How 3PLs Can Up Their Pharma Game
How 3PLs Can Up Their Pharma Game
For Industry in Flux, is M&A Jolt in Store?
For Industry in Flux, is M&A Jolt in Store?
CAR-T Therapies: Three Supply Chain Considerations
CAR-T Therapies: Three Supply Chain Considerations

Newsletter

Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.

Subscribe Now!
Related Videos
Related Content
Hospital Networks Invest in Centralized Pharmacy Hubs to Cut Costs and Strengthen Supply Chains
August 12th 2025

Hospital Networks Invest in Centralized Pharmacy Hubs to Cut Costs and Strengthen Supply Chains

Nicholas Saraceno, Editor
Pharma Pulse: Vinay Prasad Reinstated as FDA CBER Head, New COVID-19 Risk Data, and the Industry’s Response to Rising Costs
August 12th 2025

Pharma Pulse: Vinay Prasad Reinstated as FDA CBER Head, New COVID-19 Risk Data, and the Industry’s Response to Rising Costs

Nicholas Saraceno, Editor
FDA Launches PreCheck Program to Strengthen US Drug Manufacturing
August 12th 2025

FDA Launches PreCheck Program to Strengthen US Drug Manufacturing

Nicholas Saraceno, Editor
Pharma Pulse: FDA Launches Pre-Check Program, GSK Secures mRNA Settlement, and Pharma Leaders Eye US Investment Boost
August 12th 2025

Pharma Pulse: FDA Launches Pre-Check Program, GSK Secures mRNA Settlement, and Pharma Leaders Eye US Investment Boost

Nicholas Saraceno, Editor
Novo Nordisk Ramps Up Legal Fight Against Compounded Semaglutide Knockoffs
August 12th 2025

Novo Nordisk Ramps Up Legal Fight Against Compounded Semaglutide Knockoffs

Nicholas Saraceno, Editor
Esteve Expands US Footprint With Acquisition of Regis Technologies, Boosts Rare Disease Portfolio
August 12th 2025

Esteve Expands US Footprint With Acquisition of Regis Technologies, Boosts Rare Disease Portfolio

Nicholas Saraceno, Editor
© 2025 MJH Life Sciences

All rights reserved.